Serc
Designed for meniere's disease developed to alleviate vertigo symptoms.
Strengths: 8 · 16 · 24mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Histamine Analogue
- Pharmacological class
Histamine H3 Receptor Antagonist
- Contraindications
hypersensitivity to betahistine; phaeochromocytoma
- Precautions and warnings
monitor patients with asthma; use caution in patients with peptic ulcer disease
- Minor side effects
nausea; dyspepsia; headache
- Moderate side effects
abdominal distension
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Designed for meniere's disease developed to alleviate vertigo symptoms.
- Prescription status
POM
- Manufacturer
Viatris
- Onset Time
1–2 days
- Duration
3–6 months
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
antihistamines
- Age restrictions
Not recommended for children and adolescents.
Serious side effects
anaphylaxis — requires immediate medical attention; cutaneous hypersensitivity reactions — requires immediate medical attention
Mechanism of action
Serc works by acting on H1 and H3 receptors in the inner ear and vestibular nuclei, improving blood flow and reducing symptoms of vertigo and dizziness without sedation.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Consult a physician before use.
Serc
Designed for meniere’s disease developed to alleviate vertigo symptoms.
Editorial Notes
- Active ingredient(s): Betahistine
- Listed indication(s): Meniere’s Disease, Vertigo
Usually available as
- 90 tablets - 8 mg1068-8-mg-13067
- 90 tablets - 16 mg1068-16-mg-13062
- 60 tablets - 24 mg1068-24-mg-13071